AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Top Cited Papers
- 6 May 2009
- journal article
- review article
- Published by Elsevier BV in Cell Metabolism
- Vol. 9 (5), 407-416
- https://doi.org/10.1016/j.cmet.2009.03.012
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activityNature, 2009
- TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cellsThe EMBO Journal, 2009
- The Glycogen-Binding Domain on the AMPK β Subunit Allows the Kinase to Act as a Glycogen SensorCell Metabolism, 2009
- A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchangeNature, 2008
- AMPK and PPARδ Agonists Are Exercise MimeticsCell, 2008
- Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein KinasePublished by Elsevier BV ,2007
- Epigallocatechin-3-gallate (EGCG), A Green Tea Polyphenol, Suppresses Hepatic Gluconeogenesis through 5′-AMP-activated Protein KinasePublished by Elsevier BV ,2007
- AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1αProceedings of the National Academy of Sciences of the United States of America, 2007
- Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascadeBiochemical Journal, 2007
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinaseNature, 2002